Biocryst Announces Full Exercise Of Underwriters??? Option To Purchase Additional Shares And Completion Of Public Offering Of Common Stock Post author:Sam Post published:September 17, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Spark Gets FDA Greenlight for Luxturna, The First Gene Therapy for Eye Disease Approved in the U.S. December 18, 2017 Here is the One Biotech Billionaire Investors Love October 18, 2017 Rumor Alert: Sanofi Close to Scooping Up This Massachusetts Biotech in $1 Billion+ Deal March 22, 2017
Spark Gets FDA Greenlight for Luxturna, The First Gene Therapy for Eye Disease Approved in the U.S. December 18, 2017
Rumor Alert: Sanofi Close to Scooping Up This Massachusetts Biotech in $1 Billion+ Deal March 22, 2017